Biomedal, S.L. participates in an European project funded by the 7th Framework Program: “Magic Bullet”. This project is coordinated by the Andalusian Healthcare Service (SAS) to optimize the treatment of a certain type of pneumonia disease caused by antibiotic multirresistant bacteria. This type of disease is ventilation associated pneumonia (VAP), commonly acquired in intensive care units all over Europe.
Biomedal will develop a novel antimicrobial susceptibility method based on growth tests in gel microspheres aimed to obtain quicker results. The method allows the rapid implemenation of the most adecuate antimicrobial solution. First results will be presented in June in the Acinetobacter International Symposium in Cologne (Germany).